Global Coalition for Adaptive Research (GCAR) Names Gary Gordon Interim Chief Executive Officer

FOR IMMEDIATE RELEASE: November 8, 2018 CONTACT: Global Coalition for Adaptive Research Rachel Rosenstein-Sisson, Executive Assistant E-mail: rrosenstein.sisson@gcaresearch.org / Phone: 617-299-6471 National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161…

Read more

Safeway Foundation Grant Awarded to the National Foundation for Cancer Research

NFCR is one of 13 local and regional organizations to be the recipient of a grant by Safeway Foundation supporting cancer research and treatment efforts. The $35,000 award will be directed toward the expansion of the Cancer Patient Navigation Hotline.

Read more

Research Identifies Potential Guidance for Gastric Cancer Treatment

Researchers from Wake Forest Baptist Medical Center and Tianjin Medical University Cancer Institute and Hospital (TMUCIH) have discovered that gastric cancer tissue samples bearing mutation of a specific gene, MUC16, too are associated with higher tumor mutation loads.

Read more

Cytokine discovered by NFCR Fellow Paul Fisher holds promise for combating prostate cancer bone metastasis

Published study continues to build evidence that cytokine discovered by NFCR Fellow Paul Fisher holds promise for combating prostate cancer bone metastasis

Read more

Worldwide burden of cancer attributable to diabetes and high body-mass index

The International Agency for Research on Cancer (IARC) and the World Cancer Research Fund (WCRF) have concluded that there is a causal association between diabetes and high BMI and several types of cancer.  As the prevalence of  these cancer risk factors…

Read more

Quartet of NFCR Scientists Publishes Papers in Immediate Succession

FOR IMMEDIATE RELEASE: May 16, 2018 CONTACT: National Foundation for Cancer Research Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Three Articles Offer Possible Bases for Brain Cancer Treatments, Insight into Somatic Mutations  …

Read more

A new study on Gliblastoma supported by NFCR just published

In a press release from Massachusetts General Hospital titled, “Glioma subtypes determine how the dangerous brain tumors spread, evade anti-angiogenic treatment” the research of NFCR Fellow, Rakesh Jain, Ph.D. is highlighted as published online in Cancer Cell in April, 2018. The study describes,…

Read more

Two National Foundation for Cancer Research Scientists Among the National Academy of Inventors’ Latest Class

FOR IMMEDIATE RELEASE: April 5, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org / Phone: 301-961-9161 The Honor Recognizes Top Academic Inventors BETHESDA, MD – In an event this afternoon at the historic Mayflower Hotel…

Read more

Duo of Oncology Vaccine Pioneers at the National Cancer Institute to Receive 2018 Annual Szent-Györgyi Prize for Progress in Cancer Research

  FOR IMMEDIATE RELEASE: February 15, 2018 CONTACT: Bradley Gillenwater, Senior Director for Global Programs & Communications E-mail: bgillenwater@nfcr.org First Occasion for Award to Recognize Extraordinary Contributions in Cancer Prevention, Role of Vaccines BETHESDA, MD – The National Foundation for…

Read more

Attacking Metastatic Tumors in the Brain

Targeting HER3 could cripple metastatic cancers that have spread to the brain. (Bethesda, MD, June 5, 2017) Rakesh Jain, PhD, Director of the Edwin L. Steele Laboratory for Tumor Biology at the Massachusetts General Hospital and supported by the National…

Read more

Free Cancer Screening Guidelines

DOWNLOAD